Literature DB >> 8477743

Fluorescent and biotinylated linear peptides as selective bifunctional ligands for the V1a vasopressin receptor.

J Howl1, X Wang, C J Kirk, M Wheatley.   

Abstract

We have designed and synthesized a linear peptide analogue of arginine vasopressin. This peptide, [1-phenylacetyl, 2-O-methyl-D-tyrosine, 6-arginine, 8-arginine, 9-lysinamide]vasopressin (PhAcALVP), has a lysinamide residue substituted for the more usual glycinamide at position 9. Derivatization of PhAcALVP at the N epsilon-lysyl amino group with N-hydroxysuccinimide esters of aminomethylcoumarin (Mec) and biotin (Btn) produced the bifunctional ligands PhAcAL(Mec)VP and PhAcAL(Btn)VP, respectively. Pharmacological characterization of these peptides revealed that all were high-affinity V1a-selective antagonists. PhAcAL(Btn)VP can simultaneously bind to both the rat liver V1a receptor and avidin conjugates. Using this strategy, we were able to study the distribution of V1a receptors on the surface of the rat mammary tumour cell line, WRK-1. Routine epifluorescent microscopy and confocal image analysis were used to observe the distribution of avidin-Texas-Red associated with receptor-bound PhAcAL(Btn)VP. We conclude that PhAcALVP is a useful precursor for the production of hetero-bifunctional V1a-selective ligands. Both PhAcAL(Mec)VP and PheAcAL(Btn)VP can be used selectively to probe the V1a receptor and will be versatile tools for a variety of histocytochemical applications, including receptor localization and purification.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477743     DOI: 10.1111/j.1432-1033.1993.tb17811.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes.

Authors:  S R Hawtin; H C Howard; M Wheatley
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

2.  Molecular recognition of peptide and non-peptide ligands by the extracellular domains of neurohypophysial hormone receptors.

Authors:  J Howl; M Wheatley
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

3.  Identification of the glycosylation sites utilized on the V1a vasopressin receptor and assessment of their role in receptor signalling and expression.

Authors:  S R Hawtin; A R Davies; G Matthews; M Wheatley
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

Review 4.  Synthetic peptides in biochemical research.

Authors:  D C Hancock; N J O'Reilly; G I Evan
Journal:  Mol Biotechnol       Date:  1995-08       Impact factor: 2.695

5.  Novel strategies for the design of receptor-selective vasopressin analogues: Aib-substitution and retro-inverso transformation.

Authors:  J Howl; Z Prochazka; M Wheatley; J Slaninová
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 6.  Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assays and receptor studies.

Authors:  B Mouillac; M Manning; T Durroux
Journal:  Mini Rev Med Chem       Date:  2008-09       Impact factor: 3.862

7.  An improved synthesis of arsenic-biotin conjugates.

Authors:  Jorge Heredia-Moya; Kenneth L Kirk
Journal:  Bioorg Med Chem       Date:  2008-03-27       Impact factor: 3.641

Review 8.  Vasopressin: behavioral roles of an "original" neuropeptide.

Authors:  Heather K Caldwell; Heon-Jin Lee; Abbe H Macbeth; W Scott Young
Journal:  Prog Neurobiol       Date:  2007-11-04       Impact factor: 11.685

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.